Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

168 HR Clonidine 0.00833 MG/HR Transdermal System

Known as: CLONIDINE 0.2 mg in 1 d TRANSDERMAL PATCH [Clonidine], cloNIDine HCl 0.2 MG/Day Weekly Transdermal System, Clonidine 0.2 mg in 1 d TRANSDERMAL PATCH 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The current investigation sought to determine whether a standard outpatient dose of dialectical behavior therapy (DBT) skills… Expand
  • table 1
Review
2013
Review
2013
High-intensity interval training (HIT) is a well-known, time-efficient training method for improving cardiorespiratory and… Expand
  • table 2
  • table 3
  • figure 1
  • figure 2
  • figure 3
2007
2007
A33 Background: VEGFR-2 is a key regulator of angiogenesis and cancer cell growth. IMC-1121B is a recombinant human IgG1 MAb… Expand
2006
2006
Background: We wished to define the maximum tolerated dose (MTD), toxicity, and pharmacokinetics of the novel isoflav-3-ene, NV06… Expand
  • table 3
  • table 1
  • table 4
  • table 2
  • table 5
Highly Cited
2005
Highly Cited
2005
In view of the recent interest in weekly erythropoietic regimens and the lack of studies directly comparing the available agents… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
2004
2004
3031 Background: 17AAG is a benzoquinone antibiotic known to down regulate oncoproteins, by binding to heat shock protein 90… Expand
2004
2004
3031 Background: 17AAG is a benzoquinone antibiotic known to down regulate oncoproteins, by binding to heat shock protein 90… Expand